Next Article in Journal
Dendrimers for siRNA Delivery
Next Article in Special Issue
RNAi Therapeutic Platforms for Lung Diseases
Previous Article in Journal
Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease
Previous Article in Special Issue
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2013, 6(2), 124-160; doi:10.3390/ph6020124

siRNA Genome Screening Approaches to Therapeutic Drug Repositioning

Department of Infectious Diseases, University of Georgia, Animal Health Research Center, 111 Carlton Street, Athens GA 30602, USA
Author to whom correspondence should be addressed.
Received: 20 December 2012 / Revised: 10 January 2013 / Accepted: 22 January 2013 / Published: 28 January 2013
(This article belongs to the Special Issue RNAi-Based Therapeutics)
View Full-Text   |   Download PDF [594 KB, uploaded 29 January 2013]   |  


Bridging high-throughput screening (HTS) with RNA interference (RNAi) has allowed for rapid discovery of the molecular basis of many diseases, and identification of potential pathways for developing safe and effective treatments. These features have identified new host gene targets for existing drugs paving the pathway for therapeutic drug repositioning. Using RNAi to discover and help validate new drug targets has also provided a means to filter and prioritize promising therapeutics. This review summarizes these approaches across a spectrum of methods and targets in the host response to pathogens. Particular attention is given to the utility of drug repurposing utilizing the promiscuous nature of some drugs that affect multiple molecules or pathways, and how these biological pathways can be targeted to regulate disease outcome. View Full-Text
Keywords: RNAi; siRNA; miRNA; genome; antiviral; HTS; therapeutic; pathway; virus; bacteria; pathogen; reposition; repurpose; host genes RNAi; siRNA; miRNA; genome; antiviral; HTS; therapeutic; pathway; virus; bacteria; pathogen; reposition; repurpose; host genes

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Perwitasari, O.; Bakre, A.; Tompkins, S.M.; Tripp, R.A. siRNA Genome Screening Approaches to Therapeutic Drug Repositioning. Pharmaceuticals 2013, 6, 124-160.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top